Home › Psoriatic Arthritis
Psoriatic Arthritis clinical trials recruiting in the U.S.
32 studies for Psoriatic Arthritis are recruiting participants at sites across the United States.
Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. Find out about symptoms and treatment.
Cities with the most studies
- Houston, TX8 studies
- Charlotte, NC7 studies
- Altoona, PA6 studies
- Philadelphia, PA6 studies
- Tampa, FL6 studies
- Parma, OH6 studies
- New York City, NY5 studies
- San Diego, CA5 studies
- Clearwater, FL5 studies
- Milwaukee, WI5 studies
- Cleveland, OH5 studies
- Plantation, FL5 studies
- Jackson, TN4 studies
- Arlington, TX4 studies
- Albuquerque, NM4 studies
- Baytown, TX4 studies
- Thousand Oaks, CA4 studies
- Tucson, AZ4 studies
- Phoenix, AZ4 studies
- Hialeah, FL4 studies
- Seattle, WA4 studies
- Baltimore, MD4 studies
- Dallas, TX4 studies
- Kansas City, MO4 studies
- Orlando, FL4 studies
- Durham, NC4 studies
- The Woodlands, TX4 studies
- Huntington Beach, CA4 studies
- Lakeland, FL3 studies
- Lansing, MI3 studies
- Kendall, FL3 studies
- Mesquite, TX3 studies
- Salt Lake City, UT3 studies
- Cincinnati, OH3 studies
- Austin, TX3 studies
- Brooklyn, NY3 studies
- Lubbock, TX3 studies
- Portland, OR3 studies
- Mesa, AZ3 studies
- St. Louis, MO3 studies
By state
- Arizona8 studies
- Arkansas4 studies
- California13 studies
- Colorado4 studies
- Connecticut3 studies
- District of Columbia3 studies
- Florida14 studies
- Georgia7 studies
- Illinois6 studies
- Indiana4 studies
- Kentucky4 studies
- Maryland7 studies
- Massachusetts4 studies
- Michigan4 studies
- Missouri5 studies
- New Jersey3 studies
- New Mexico4 studies
- New York9 studies
- North Carolina11 studies
- Ohio14 studies
- Oregon3 studies
- Pennsylvania12 studies
- South Carolina3 studies
- Tennessee7 studies
- Texas17 studies
- Utah3 studies
- Washington6 studies
- Wisconsin5 studies
Recently updated studies
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06807424A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07321873A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
RecruitingPhase 3
Ages 3 and older · All sexes · Updated Sep 25, 2026 · NCT06663332A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 25, 2026 · NCT07801495Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
RecruitingPhase 1
Ages 18 and older · Women · Updated Sep 18, 2026 · NCT06888193A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 14, 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06671496Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07286058A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07280702A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
RecruitingPhase 4
Ages 18 and older · Women · Updated Aug 28, 2026 · NCT07654751Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Recruiting
Ages 18 to 100 · All sexes · Updated Aug 10, 2026 · NCT07180537Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT07111494Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07138898A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT07290036Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
Recruiting
All ages · All sexes · Updated Jun 10, 2026 · NCT06586281Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT04751396A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT06454188Rheumatology Patient Registry and Biorepository
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 99 · All sexes · Updated Feb 13, 2026 · NCT04402086Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Jan 22, 2026 · NCT04806620Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT06865105From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.